CN101502580A - External-use medicament for treating tinea manus and pedis - Google Patents
External-use medicament for treating tinea manus and pedis Download PDFInfo
- Publication number
- CN101502580A CN101502580A CNA2009100216151A CN200910021615A CN101502580A CN 101502580 A CN101502580 A CN 101502580A CN A2009100216151 A CNA2009100216151 A CN A2009100216151A CN 200910021615 A CN200910021615 A CN 200910021615A CN 101502580 A CN101502580 A CN 101502580A
- Authority
- CN
- China
- Prior art keywords
- parts
- fructus
- powder
- cortex
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides an externally applied medicament for treating tinea of hands and feet, consisting of three parts of powders A, electuary B and spray C, and the main ingredients comprise lightyellow sophora root, giant knotweed rhizome, dark plum fruit, salicylic acid, ketoconazole and the like, thereby having the effects of clearing heat, removing toxin, sterilization and anti-inflammation. The medicament is different from the previous simple treatment proposals for treating the tinea of hands and feet, the powers A is firstly used for rapidly killing pathogens at the skin surface, changing the infected lesion skin tissue structure of the surface, leading the structure to be loose and forming a smooth channel which is conductive to the penetration of the medicament, then the electuary B is used under the premise of the channel for dredging the penetration of the medicament, thereby rapidly and thoroughly killing the pathogens in skin, the spray C is used for powerful sterilization, keeping a clean environment for the skin and achieving the effect of no recurrence. The medicament carries out multi-level three-dimensional treatment, simultaneously realizes the treatment of external and internal diseases, combines the prevention with the treatment and simultaneously treats both principal and secondary aspect of disease, thereby realizing the special treatment method and reliable efficacy.
Description
Technical field
The present invention relates to a kind of topical agent for the treatment of tinea manus and pedis.
Background technology
Tinea manus and pedis is meant the dermatosis that pathogenic skin filamentous fungi causes at brothers' site infection.According to site of pathological change, can divide into the tinea manuum and tinea pedis again.The tinea manuum is commonly called as " fungal infection of hand and foot ", and tinea pedis is commonly called as " beriberi ".The sickness rate of tinea pedis is high far beyond the tinea manuum, and is particularly common in China south.
1. cause of disease primary disease mainly causes that by infection such as trichophyton, alpha fungus, microsporon gypseum and acrothesium floccosums wherein trichophyton accounts for more than 50%.In recent years, Candida albicans and other yeast infections have the trend of increasing.Primary disease mainly is communicated by contact, with hands scratch grab the position of suffering from tinea or with the shared footgear of patient, glove, bath towel, foot washing basin etc. be main route of transmission.Tinea pedis is again the important source of infection of the tinea manuum and tinea cruris and tinea corporis.Fungus misses potter darkness and moist place, thereby summer is more than winter, China's southern climates warm moist, and sickness rate is higher than the north.In recent years, the people who wears nylon sock, plastic shoes, rubber overshoes is more and more, these goods suctions and breathability are all poor, summer and autumn particularly, the weather sweltering heat often hinders the evaporation of sufficient antiperspirant, causes the living environment of conk, breeding, add that antiperspirant is the best culture medium of fungus, thereby tinea pedis is more and more general.There are confidential relation at the morbidity and the age of tinea manus and pedis, and general adolescent is ill more, and that old man and child fall ill is less; The strong people of body constitution is than Low people's sickness rate height; People's sickness rate height that the people of foot hyperhidrosis lacks than sufficient antiperspirant.In addition, with occupation substantial connection is arranged also, it is many that the people of wet environment work suffers from tinea pedis than the people of dry environment work.
2. clinical manifestation hands, tinea pedis (particularly tinea pedis) are modal superficial mycosis, and summer and autumn, the sickness rate height often showed as the light or Xia Fadong of Xia Chongdong more.Involve the adult, M-F does not have significant difference more.The many sides by limbs of skin lesion are transmitted to offside.According to clinical characters, hands, tinea pedis often are divided into 3 types: 1. vesicle squama type: good send out in refer between (toe), the centre of the palm, the sufficient sole of the foot and sufficient lateral margin.Skin lesion from the beginning of be the needle point size deeply in the property vesicle, limpid vesicle fluid, bleb wall thickness and shinny is difficult for ulceration, vesicle is dispersed in or troops, and can be fused into many rooms property bulla.After tearing the bleb wall off, expose honeycomb substrate and cherry rotten to the corn face, pruritus is obvious.Vesicle is dry after a couple of days, presents eckband shape or lamellar desquamation, and skin lesion can constantly spread towards periphery.During stable disease, based on desquamation.When the parasitical fungi breeding enlivened, erythema, pimple can take place on the basis that skin lesion thickens.At this moment, gargalesthesia can be arranged.2. hyperkeratotic pattern: this kind of is characterized as no vesicle and pustule, and how dry the part is, and skin lesion place cutin thickens, rough surface desquamation, texture are deepened, and easily chaps, hemorrhage, and skin lesion also can spread to the instep.General no pruritus or pruritus are slight.When chapping, pain.Obvious with winter, can not recover summer sometimes.Good sending out in heel and palm sole of the foot portion.3. flood erosive type: under the environment of warm moist, fungus parasitizes between toe for a long time, and fertility strengthens, and easily causes horny layer of epidermis and thickens, and because of the humidity dipping turns white, have often with hyperhidrosis.This kind of good sending out in referring to (toe) seam refers to see between (toe) with the 3rd～4 and 4～5 especially.Show as skin dipping and turn white, the surface is soft, easily strip off, and exposes red rotten to the corn face, even the crack.Pruritus is in various degree arranged, during the secondary bacterial infection, the foul smelling flavor.
Suffer from the patient of tinea pedis, pruritus is often arranged, increase the weight of night.Owing to very itch unbearably, to scratch, rub with hands, skin is rubbed broken back with the hands and is flowed out secretions, localized desquamation or incrustation, outbreak repeatedly can not be worn footgear when serious, and usually be caused the tinea manuum and tinea corporis.
Primary disease Chang Yiyi type is main, or several types exists simultaneously, also can turn to another type from a type, as showing as the vesicle squama type summer, then shows as hyperkeratotic pattern winter.Treatment thoroughly is not the one of the main reasons that causes its protracted course of disease.Tinea pedis (especially flooding erosive type) is the secondary bacterial infection easily, pustule, ulcer occur, even secondary acute lymphangitis, lymphadenitis, cellulitis or erysipelas inflammatory reaction also can cause Tinea and microbid when obvious.
3. the histopathology pathological changes is positioned at epidermis and high dermis.Common change into spongiform pustule or vesicle in the epidermis, the mixed type cell infiltration occurs around the high dermis blood vessel, can be acute, subacute and even chronic inflammatory disease changes.Acute stage: visible slight hyperkeratosis companion parakeratosis, reach intercellular edema in the spine cell, microabscess in spinous layer top spongiform pustule or the horny layer is often arranged.The infiltration of mild to moderate lymphocyte and neutrophilic granulocyte is arranged, papilledema around the high dermis blood vessel.Then enter subacute stage: epidermal hyperplasia, high dermis blood vessel hyperplasia, expansion have a small amount of eosinophilic granulocyte or plasma cell to mix between above-mentioned inflammatory cell.Chronic phase: obvious hyperkeratosis, the moderate acanthosis, high dermis vasodilation, inflammatory reaction alleviates, and based on lymphocyte.Trichophyton verrucosum and trichophyton still can be involved hair follicle, and inflammatory reaction is violent due to the Trichophyton verrucosum, neutrophil accumulation can occur, promptly show as collection bunch property folliculitis type clinically.
4 preventions and treatment
4.1 the prevention key is to note individual, family and collective's health.Superficial mycosis should be noted in time, be treated up hill and dale to the control source of infection; The footgear that sweep gas is good keeps the foot drying; In the daily life, also should avoid acid-base material, carry out self-protection damage of hand skin etc.; The articles for daily uses such as not shared footgear, bathtub, foot washing basin and nail scissors are cut off the route of transmission, in order to avoid infect.Economical and practical have certain effect, and practical operation is got up not very convenient.
4.2 the external medication primary disease, is treated successful key based on external medication and is to adhere to medication, generally need 1～2 month the course of treatment; Hyperkeratotic pattern tinea manus and pedis or medicine for external use unsatisfactory curative effect person can consider the treatment of innerlich anwenden thing.Should select different processing methods according to different Clinical types:, should select bland cream and water preparation (as bifonazole frost or solution etc.) as the vesicle squama type; To dipping erosive type person, give cold wet compresses such as lead acetate solution, boric acid solution, wait to ooze out not for a long time, give powder (as alumen powder, miconazole powder etc.) again, after the skin lesion drying, external-application cream, water preparation etc. again should not be with the medicines that zest is big, stripping off property is strong; The hyperkeratotic pattern patient does not have when chapping, and the available stronger preparation of effect (as whitfield ointment or tincture etc.) that strips off when chapping, should be selected relatively mild preparation (as terbinafine ointment etc.) for use, in case of necessity, can adopt the package therapy.Compound preparation such as tinea manus and pedis cream, tinea manus and pedis ointment etc. are arranged, also have the Chinese medicine proved recipe, the cycle is long, and effect is slow.
4.3 the treatment of innerlich anwenden thing can oral itraconazole (100mg/d, decoction being taken at a draught, 15 days courses of treatment) or terbinafine (250mg/d, 4 weeks of the course of treatment).During tinea pedis secondary bacterial infection, should use the antibiotic control infection earlier, use antifungal drug then; When causing Tinea and microbid, should in active treatment activeness focus, give Claritin.Medicining cycle is long, and to the Liver and kidney toxic side effect, financial burden is heavy.
Summary of the invention
The objective of the invention is at the deficiencies in the prior art, a kind of topical agent for the treatment of tinea manus and pedis is provided, this curative effect of medicine height, expense is low, and is easy to use simple and direct, has no side effect, and do not recur after healing.
Medicament of the present invention is made up of powder A, unguentum B, spray C three parts, and wherein powder A is made by weight by following bulk drugs: 220-280 parts of Radix Sophorae Flavescentiss, 150-250 parts of Cortex Dictamni, 100-200 parts of Rhizoma Polygoni Cuspidati, 80-120 parts in Alumen, 150-230 parts of salicylic acid, 80-130 parts in benzoic acid.
Unguentum B is made of by weight following bulk drugs: 200-300 parts of Herba Senecionis Scandentiss, 200-300 parts of Cortex Phellodendris, 200-300 parts of Fructus Mumes, 100-200 parts of Sal Ammoniacus, 1.5-5 parts of ketoconazoles, 10-20 parts of laurocaprams, 330-410 parts in vaseline, 320-390 parts of lanolines.
Spray C is made of by weight following bulk drugs: 15-35 parts of Oleum Ocimi Gratissimis, 35-45 parts of Fructus Cnidiis, 35-45 parts of the Fructus Kochiae, 45-55 parts of Fructus Bruceaes, 35-45 parts of Herba Pogostemoniss, 35-45 parts of the Radixs Stemonae, 35-45 parts of Cortex Pseudolariciss, 35-45 parts of Radix Et Rhizoma Rhei.
The preparation technology of powder A is: by recipe quantity weighing respectively distinguish the flavor of medical material and crude drug, Radix Sophorae Flavescentis, Rhizoma Polygoni Cuspidati, Cortex Dictamni, alum powder are broken into fine powder (crossing 100 mesh sieves), and mixing is standby; With salicylic acid, benzoic acid respectively powder become fine powder (cross 100 mesh sieves); Add gradually in the above-mentioned mixed powder in the prescription ratio, mix, evenly, promptly.
The preparation technology of unguentum B is: Sal Ammoniacus, ketoconazole are ground into fine powder (crossing 100 mesh sieves), and mixing, standby; The decocting that Herba Senecionis Scandentis, Cortex Phellodendri, Fructus Mume add 8 times of amounts boiled 2 hours, filtered, and medicinal residues add 6 times of water gagings and decocted 1.5 hours, filtered, and merging filtrate is concentrated into the clear paste of relative density 1.20-1.25 (60 ℃); After vaseline, the lanoline heating melting, constantly stir, add laurocapram and continue stirring and evenly mixing, treat to add when temperature is reduced to 45-55 ℃ above-mentioned clear paste and stir mixing; Add ketoconazole, Sal Ammoniacus fine powder, stir, mixing, promptly.
The preparation technology of spray C is: except that Oleum Ocimi Gratissimi, Fructus Cnidii, the Fructus Kochiae, Fructus Bruceae, Herba Pogostemonis, the Radix Stemonae, Cortex Pseudolaricis, rhubarb medicinal material are ground into coarse powder, are solvent with 75% ethanol, with 1-3ml/min.kg percolation, collect 4 times of liquid of filtering, leave standstill, get supernatant; Add Oleum Ocimi Gratissimi, stirring and evenly mixing, promptly.
Characteristics of the present invention
1. technical breakthrough, the present invention adopts unique infiltration technology, at many levels, multi-facetedly kill pathomycete, various breeding approach and the mode of blocking-up pathomycete, can kill superficial fungi rapidly, effectively improve the ability that medicament sees through the epidermis collenchyme, solve that medicine in the past is difficult to see through the epidermis collenchyme and a difficult problem of eradicating tinea manus and pedis rapidly, guarantee the therapeutic effect of tinea manus and pedis, prevent recurrence.
2. the main component of this medicament is made up of plant acid, utilizes reparation, the maintenance function of plant acid pair cell, adds multiple Chinese herbal medicine active component, and the molecule granularity is minimum, and penetrating power is strong, and medicament can infiltrate subcutaneous fast, without any side effects to human body.
3. directly impose on the affected part, Transdermal absorption, medicine directly infiltrates focus deep skin tissue.Avoid the loss of medication amount and to human viscera organ's poisoning.
4. product is through a large amount of clinical verifications, and it is to epiderm skin tissue, subcutaneous tissue not damaged, and nonirritant has no side effect.Clinical experience and the gains in depth of comprehension summed up are for many years created out the simple and direct practical and effective three-dimensional therapy of three steps of " just killing epidermis superficial fungi+continue cortex deep layer fungal infection+create the rehabilitation control environment simultaneously to prevent recurrent infection extremely ", solved a difficult problem how to eliminate the cause of disease, solve the difficult problem of deep medicament infiltration, solved the more difficult problem of back recurrence.
Description of drawings
Fig. 1 is the technological process of production figure of powder A.
Fig. 2 is the technological process of production figure of unguentum B.
Fig. 3 is the technological process of production figure of spray C.
Specific embodiment
1. prepare powder A
Press column weight amount weighting raw materials (unit: g)
Radix Sophorae Flavescentis 250g, Cortex Dictamni 200g, Rhizoma Polygoni Cuspidati 150g, Alumen 100g, salicylic acid 200g, benzoic acid 100g.
The Chinese crude drug of respectively distinguishing the flavor of in will writing out a prescription is stipulated clean system down according to each kind item of Chinese Pharmacopoeia, by the recipe quantity weighing medical material of respectively distinguishing the flavor of, Radix Sophorae Flavescentis, Cortex Dictamni, Rhizoma Polygoni Cuspidati, alum powder are broken into fine powder (crossing 100 mesh sieves), salicylic acid, benzoic acid pulverize separately are become fine powder (crossing 100 mesh sieves), add in the mixed powder gradually in the prescription ratio and to mix, mix homogeneously gets final product.
2. prepare unguentum B
Press column weight amount weighting raw materials (unit: g)
Herba Senecionis Scandentis 250g, Cortex Phellodendri 250g, Fructus Mume 250g, Sal Ammoniacus 150g, ketoconazole 2g, laurocapram 15g, vaseline 350g, lanoline 350g.
The Chinese crude drug of respectively distinguishing the flavor of in will writing out a prescription is stipulated clean system down according to Chinese Pharmacopoeia and this kind item of drug standard, and Sal Ammoniacus, ketoconazole are ground into fine powder (crossing 100 mesh sieves) mixing, and is standby; The decocting that Herba Senecionis Scandentis, Cortex Phellodendri, Fructus Mume add 8 times of amounts boiled 2 hours, filtered, and medicinal residues add 6 times of water gagings and decocted 1.5 hours, filtered, and merging filtrate is concentrated into the clear paste of relative density 1.20-1.25 (60 ℃); After vaseline 350g, the lanoline 350g heating melting, constantly stir, add laurocapram and continue stirring and evenly mixing, treat to add when temperature is reduced to 45-55 ℃ above-mentioned clear paste, stir, mixing adds ketoconazole, Sal Ammoniacus powder and fine powder, stir, and mixing, promptly.
3. preparation spray C
Press column weight amount weighting raw materials (unit: g)
Oleum Ocimi Gratissimi 25g, Fructus Cnidii 40g, Fructus Kochiae 40g, Fructus Bruceae 50g, Herba Pogostemonis 40g, Radix Stemonae 40g, Cortex Pseudolaricis 40g, Radix Et Rhizoma Rhei 40g.
The Chinese crude drug of respectively distinguishing the flavor of in will writing out a prescription is stipulated clean system down according to each kind item of Chinese Pharmacopoeia, except that Oleum Ocimi Gratissimi, Fructus Cnidii, the Fructus Kochiae, Fructus Bruceae, Herba Pogostemonis, the Radix Stemonae, Cortex Pseudolaricis, rhubarb medicinal material are ground into coarse powder, with 75% ethanol is solvent (1000-1500 part), with 1-3ml/min.kg percolation, collect 4 times of liquid of filtering, leave standstill, get supernatant; Add Oleum Ocimi Gratissimi, stirring and evenly mixing, promptly.Using method
1. use earlier powder A
Powder A10g (one bag) is put into the boiling water of 1000ml; Big as requirement, this product 20g can be put into the boiling water of 1500ml, need stir during use, dissolving treats that water temperature is suitable, and the dipping erosive hands and feet tinea soaked 10-20 minutes, and vesicle squama type, hyperkeratotic pattern tinea manus and pedis soaked 20-30 minutes, dried.1 week of logotype was 1 course of treatment, general 1～2 course of treatment.
2. the inferior unguentum B that uses
Unguentum B is applied to above-mentioned every day 2-3 times, 1 week of logotype was 1 course of treatment through embathing the tinea manus and pedis affected part with powder A, general 1～2 course of treatment.
3. reuse spray C
Spray C is sprayed on tinea manus and pedis affected part and the medicated clothing footgear that contacts with the affected part, every day 2-3 times, the articles for daily use such as foot basin etc. once a day, 1 week of logotype was 1 course of treatment, general 1～2 course of treatment.
Claims (3)
1, a kind of topical agent for the treatment of tinea manus and pedis, form by powder A, unguentum B, spray C three parts, it is characterized in that powder A is made by weight by following bulk drugs: 220-280 parts of Radix Sophorae Flavescentiss, 150-250 parts of Cortex Dictamni, 100-200 parts of Rhizoma Polygoni Cuspidati, 80-120 parts in Alumen, 150-230 parts of salicylic acid, 80-130 parts in benzoic acid;
Unguentum B is made by weight by following bulk drugs: 200-300 parts of Herba Senecionis Scandentiss, 200-300 parts of Cortex Phellodendris, 200-300 parts of Fructus Mumes, 100-200 parts of Sal Ammoniacus, 1.5-5 parts of ketoconazoles, 10-20 parts of laurocaprams, 330-410 parts in vaseline, 320-390 parts of lanolines;
Spray C is to be made by weight by following bulk drugs: 15-35 parts of Oleum Ocimi Gratissimis, 35-45 parts of Fructus Cnidiis, 35-45 parts of the Fructus Kochiae, 45-55 parts of Fructus Bruceaes, 35-45 parts of Herba Pogostemoniss, 35-45 parts of the Radixs Stemonae, 35-45 parts of Cortex Pseudolariciss, 35-45 parts of Radix Et Rhizoma Rhei.
2, a kind of topical agent for the treatment of tinea manus and pedis as claimed in claim 1 is characterized in that powder A is made by weight by following bulk drugs: 250 parts of Radix Sophorae Flavescentiss, 200 parts of Cortex Dictamni, 150 parts of Rhizoma Polygoni Cuspidati, 100 parts in Alumen, 200 parts of salicylic acid, 100 parts in benzoic acid;
Unguentum B is made by weight by following bulk drugs: 250 parts of Herba Senecionis Scandentiss, 250 parts of Cortex Phellodendris, 250 parts of Fructus Mumes, 150 parts of Sal Ammoniacus, 2 parts of ketoconazoles, 15 parts of laurocaprams, 350 parts in vaseline, 350 parts of lanolines;
Spray C is to be made by weight by following bulk drugs: 25 parts of Oleum Ocimi Gratissimis, 40 parts of Fructus Cnidiis, 40 parts of the Fructus Kochiae, 50 parts of Fructus Bruceaes, 40 parts of Herba Pogostemoniss, 40 parts of the Radixs Stemonae, 40 parts of Cortex Pseudolariciss, 40 parts of Radix Et Rhizoma Rhei.
3, treat the preparation method of the topical agent of tinea manus and pedis as claimed in claim 1 or 2, it is characterized in that
The preparation method of powder A is: take by weighing respectively distinguish the flavor of medical material and crude drug by recipe quantity, Radix Sophorae Flavescentis, Cortex Dictamni, Rhizoma Polygoni Cuspidati, alum powder are broken into fine powder, cross 100 mesh sieves, and mixing is standby; With salicylic acid, benzoic acid respectively powder become fine powder, cross 100 mesh sieves; Add gradually in the above-mentioned mixed powder in the prescription ratio, mix, evenly, promptly;
The preparation method of unguentum B is: Sal Ammoniacus, ketoconazole is ground into fine powder, crosses 100 mesh sieves, and mixing, standby; The decocting that Herba Senecionis Scandentis, Cortex Phellodendri, Fructus Mume add 8 times of amounts boiled 2 hours, filtered, and medicinal residues add 6 times of water gagings and decocted 1.5 hours, filter, and merging filtrate, being concentrated into relative density is 1.20-1.25 clear paste at 60 ℃; After vaseline, the lanoline heating melting, constantly stir, add laurocapram and continue stirring and evenly mixing, treat to add when temperature is reduced to 45-55 ℃ above-mentioned clear paste and stir mixing; Add ketoconazole, Sal Ammoniacus fine powder, stir, mixing, promptly;
The preparation method of spray C is: except that Oleum Ocimi Gratissimi, Fructus Cnidii, the Fructus Kochiae, Fructus Bruceae, Herba Pogostemonis, the Radix Stemonae, Cortex Pseudolaricis, rhubarb medicinal material are ground into coarse powder, are solvent with 75% ethanol, with 1-3ml/min.kg percolation, collect 4 times of liquid of filtering, leave standstill, get supernatant; Add Oleum Ocimi Gratissimi, stirring and evenly mixing, promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100216151A CN101502580B (en) | 2009-03-20 | 2009-03-20 | External-use medicament for treating tinea manus and pedis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009100216151A CN101502580B (en) | 2009-03-20 | 2009-03-20 | External-use medicament for treating tinea manus and pedis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101502580A true CN101502580A (en) | 2009-08-12 |
| CN101502580B CN101502580B (en) | 2011-02-02 |
Family
ID=40975042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009100216151A Active CN101502580B (en) | 2009-03-20 | 2009-03-20 | External-use medicament for treating tinea manus and pedis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101502580B (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102008673A (en) * | 2010-12-07 | 2011-04-13 | 贾孝荣 | Medicine composition for treating tinea manus and pedis |
| CN102389551A (en) * | 2011-11-26 | 2012-03-28 | 沈志强 | Medicament used for beriberi treatment and foot-bath health care |
| CN103055169A (en) * | 2012-02-27 | 2013-04-24 | 汪世龙 | External use plaster for treating hypertensive disease |
| CN103055263A (en) * | 2012-02-27 | 2013-04-24 | 汪世龙 | External use plaster for treating breast hyperplasia |
| CN103071113A (en) * | 2012-02-27 | 2013-05-01 | 汪世龙 | Externally-applied drug for curing psoriasis |
| CN103705604A (en) * | 2013-12-14 | 2014-04-09 | 张英芹 | Traditional Chinese medicine for treating tinea manuum |
| CN104288290A (en) * | 2014-10-27 | 2015-01-21 | 武汉中博绿亚生物科技有限公司 | Spray for treating fungus infection on body surface of pet and preparation method of spray |
| CN105311516A (en) * | 2015-11-28 | 2016-02-10 | 史克勇 | Compound traditional Chinese medicine for treating tinea pedis |
| CN104288290B (en) * | 2014-10-27 | 2017-01-04 | 武汉中博绿亚生物科技有限公司 | A kind of spray for treating house pet body surface fungal infection and preparation method thereof |
| CN107823433A (en) * | 2017-11-23 | 2018-03-23 | 沈阳万润生物科技有限公司 | A kind of comfortable Chinese drugs agentia of pin and usage thereof |
| CN108392515A (en) * | 2018-06-07 | 2018-08-14 | 李哲 | A kind of tinea of feet and hands treatment liquid |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1098301A (en) * | 1993-08-04 | 1995-02-08 | 赵世平 | Skin-care tinea pedis medicine and preparation method thereof |
| CN1129561A (en) * | 1994-08-15 | 1996-08-28 | 梁红 | Medicine liquid for tinea |
| CN1058866C (en) * | 1996-09-23 | 2000-11-29 | 牛德英 | Medicinal composition for treating tinea manus and pedis |
| CN1284332A (en) * | 1999-08-13 | 2001-02-21 | 张朝秀 | Onychomycosis cream and its production process |
| CN1151811C (en) * | 2001-01-04 | 2004-06-02 | 黄兆元 | Pain-relieving notoginseng mixture |
| CN101195008B (en) * | 2006-12-05 | 2010-08-18 | 来柏龄 | Cattail pollen skin cleaning agent for treating gynecology disease and technique of preparing the same thereof |
-
2009
- 2009-03-20 CN CN2009100216151A patent/CN101502580B/en active Active
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102008673B (en) * | 2010-12-07 | 2011-12-07 | 贾孝荣 | Medicine composition for treating tinea manus and pedis |
| CN102008673A (en) * | 2010-12-07 | 2011-04-13 | 贾孝荣 | Medicine composition for treating tinea manus and pedis |
| CN102389551A (en) * | 2011-11-26 | 2012-03-28 | 沈志强 | Medicament used for beriberi treatment and foot-bath health care |
| CN103055263B (en) * | 2012-02-27 | 2014-05-14 | 汪世龙 | External use plaster for treating breast hyperplasia |
| CN103055169A (en) * | 2012-02-27 | 2013-04-24 | 汪世龙 | External use plaster for treating hypertensive disease |
| CN103055263A (en) * | 2012-02-27 | 2013-04-24 | 汪世龙 | External use plaster for treating breast hyperplasia |
| CN103071113A (en) * | 2012-02-27 | 2013-05-01 | 汪世龙 | Externally-applied drug for curing psoriasis |
| CN103705604A (en) * | 2013-12-14 | 2014-04-09 | 张英芹 | Traditional Chinese medicine for treating tinea manuum |
| CN104288290A (en) * | 2014-10-27 | 2015-01-21 | 武汉中博绿亚生物科技有限公司 | Spray for treating fungus infection on body surface of pet and preparation method of spray |
| CN104288290B (en) * | 2014-10-27 | 2017-01-04 | 武汉中博绿亚生物科技有限公司 | A kind of spray for treating house pet body surface fungal infection and preparation method thereof |
| CN105311516A (en) * | 2015-11-28 | 2016-02-10 | 史克勇 | Compound traditional Chinese medicine for treating tinea pedis |
| CN107823433A (en) * | 2017-11-23 | 2018-03-23 | 沈阳万润生物科技有限公司 | A kind of comfortable Chinese drugs agentia of pin and usage thereof |
| CN108392515A (en) * | 2018-06-07 | 2018-08-14 | 李哲 | A kind of tinea of feet and hands treatment liquid |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101502580B (en) | 2011-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101502580B (en) | External-use medicament for treating tinea manus and pedis | |
| CN101167847B (en) | Traditional Chinese medicinal white spirit preparation for effectively treating skin disease | |
| CN107970275A (en) | A kind of topical agent for treating tinea of feet and hands | |
| CN102178837A (en) | Chinese medicinal composition for treating tinea pedis in insoles | |
| CN102114217B (en) | Traditional Chinese medicine fumigant for treating tinea capitis | |
| CN1326546C (en) | Pure Chinese medicinal preparation for external treating burn and scald | |
| CN102755573A (en) | External use traditional Chinese medicine for treating onychomycosis | |
| CN101214367B (en) | Chinese medicine for treating manus and tinea pedis | |
| CN104189182A (en) | Traditional Chinese medicine lotion used for treating beriberi | |
| CN101601768B (en) | Chinese medicinal composition for treating tinea pedis and scabies and preparation method thereof | |
| CN103432551A (en) | Externally applied medicine for treating scapulohumeral periarthritis, radiohumeral bursitis and inexplicable ostalgia | |
| CN103239660B (en) | Medicine for treating beriberi | |
| CN102988934A (en) | Prescription of traditional Chinese medicine for treating beriberi and use method thereof | |
| CN105267811A (en) | Externally-used granule treating manus and tinea pedis, and preparation method and application thereof | |
| CN102784343B (en) | External use traditional Chinese medicine preparation for treating psoriasis | |
| CN104873587A (en) | Chinese herbal medicine for treating pain in heel | |
| CN106822593A (en) | Acne spirit nanoemulsions | |
| CN102727794B (en) | Traditional Chinese medical prescription for treating burn and scald, traumatic injury and rheumatism bone pain | |
| CN105477069A (en) | External medical composition for treating tinea pedis | |
| CN101559127B (en) | Traditional Chinese medicine ointment for treating stage II chemotherapy-induced phlebitis and preparation method | |
| CN1895348A (en) | Externally-applied medicine | |
| CN104383217A (en) | Traditional Chinese medicine composition for treating dermatophytosis and preparation method of traditional Chinese medicine composition | |
| CN103372077A (en) | Medicament for treating tinea pedis | |
| CN102319324A (en) | Medicine for treating beriberi | |
| CN106344837A (en) | Traditional Chinese medicine composition for treating dermatophytosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20160608 Address after: 237000 Shouxian County Road, Lu'an Economic Development Zone, Lu'an, Anhui Patentee after: Anhui Shilong biological medicine science and Technology Co Ltd Address before: 710075 Shaanxi city of Xi'an province high tech Zone Road new Department of building B block 2302 Patentee before: Wang Shilong |